Michael J. Morse

3.9k total citations · 3 hit papers
32 papers, 2.9k citations indexed

About

Michael J. Morse is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, Michael J. Morse has authored 32 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 13 papers in Pulmonary and Respiratory Medicine and 4 papers in Urology. Recurrent topics in Michael J. Morse's work include Bladder and Urothelial Cancer Treatments (16 papers), Urinary and Genital Oncology Studies (15 papers) and Testicular diseases and treatments (7 papers). Michael J. Morse is often cited by papers focused on Bladder and Urothelial Cancer Treatments (16 papers), Urinary and Genital Oncology Studies (15 papers) and Testicular diseases and treatments (7 papers). Michael J. Morse collaborates with scholars based in United States, Canada and United Kingdom. Michael J. Morse's co-authors include Willet F. Whitmore, Harry W. Herr, Pramod C. Sogani, Howard I. Scher, Nancy L. Geller, Alan Yagoda, Robin C. Watson, Cora N. Sternberg, William R. Fair and Lora Weiselberg and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Michael J. Morse

30 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

1989 540 citations Cora N. Sternberg, Alan Yagoda et al. Cancer profile →
Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the Urothelium

1985 513 citations Cora N. Sternberg, Alan Yagoda et al. The Journal of Urology profile →
M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Transitional Cell Carcinoma of the Urothelium

1988 492 citations Cora N. Sternberg, Alan Yagoda et al. The Journal of Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael J. Morse United States	19	2.4k	889	664	442	330	32	2.9k
Melvin L. Samuels United States	28	1.5k 0.6×	1.1k 1.3×	614 0.9×	80 0.2×	483 1.5×	44	2.5k
Wyland F. Leadbetter United States	23	1.2k 0.5×	1.1k 1.3×	353 0.5×	899 2.0×	502 1.5×	50	2.7k
Renate Pichler Austria	26	1.0k 0.4×	670 0.8×	491 0.7×	377 0.9×	437 1.3×	142	2.0k
John A. McCaffrey United States	14	1.4k 0.6×	400 0.4×	464 0.7×	94 0.2×	175 0.5×	33	1.6k
Hemant Tongaonkar India	22	660 0.3×	431 0.5×	292 0.4×	207 0.5×	267 0.8×	78	1.5k
F Flamant France	33	933 0.4×	1.6k 1.8×	774 1.2×	36 0.1×	484 1.5×	96	2.9k
Tomoyasu Tsushima Japan	25	673 0.3×	700 0.8×	304 0.5×	218 0.5×	489 1.5×	101	1.6k
Claude Merrin United States	20	612 0.3×	491 0.6×	264 0.4×	88 0.2×	144 0.4×	56	1.1k
M. Kuczyk Germany	12	798 0.3×	793 0.9×	241 0.4×	221 0.5×	659 2.0×	31	1.6k
Adam Pawinski Norway	21	705 0.3×	558 0.6×	583 0.9×	161 0.4×	414 1.3×	69	1.6k

Countries citing papers authored by Michael J. Morse

Since Specialization

Citations

This map shows the geographic impact of Michael J. Morse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Morse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Morse more than expected).

Fields of papers citing papers by Michael J. Morse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Morse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Morse. The network helps show where Michael J. Morse may publish in the future.

Co-authorship network of co-authors of Michael J. Morse

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Morse. A scholar is included among the top collaborators of Michael J. Morse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Morse. Michael J. Morse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Massaro, Peter, et al.. (2014). Squamous cell carcinoma of the suprapubic tract: A rare presentation in patients with chronic indwelling urinary catheters. Canadian Urological Association Journal. 8(7-8). 510–510. 13 indexed citations

Brenner, Phillip, H.W. Herr, Michael J. Morse, et al.. (1996). Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis.. Journal of Clinical Oncology. 14(6). 1765–1769. 65 indexed citations

Brenner, Phillip, Paul Russo, David P. Wood, et al.. (1995). Salvage radical prostatectomy in the management of locally recurrent prostate cancer after ¹²⁵ I implantation. British Journal of Urology. 75(1). 44–47. 33 indexed citations

Wood, David P., H.W. Herr, Robert J. Motzer, et al.. (1992). Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers. Cancer. 70(9). 2354–2357. 53 indexed citations

Toner, Guy C., David M. Panicek, R T Heelan, et al.. (1990). Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection.. Journal of Clinical Oncology. 8(10). 1683–1694. 199 indexed citations

Herr, Harry W., Willet F. Whitmore, Michael J. Morse, et al.. (1990). Neoadjuvant Chemotherapy in Invasive Bladder Cancer: The Evolving Role of Surgery. The Journal of Urology. 144(5). 1083–1088. 34 indexed citations

Wallner, Kent E., Dattatreyudu Nori, Michael J. Morse, et al.. (1990). ¹²⁵ Iodine Reimplantation for Locally Progressive Prostatic Carcinoma. The Journal of Urology. 144(3). 704–706. 46 indexed citations

Sternberg, Cora N., Alan Yagoda, Howard I. Scher, et al.. (1989). Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer. 64(12). 2448–2458. 540 indexed citations breakdown →

Carroll, Peter R., et al.. (1988). Testicular germ cell tumor in patient with klinefelter syndrome. Urology. 31(1). 72–74. 18 indexed citations

10.

Sternberg, Cora N., Alan Yagoda, Harry W. Herr, et al.. (1988). M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium.. PubMed. 260. 481–5. 2 indexed citations

11.

Sternberg, Cora N., Alan Yagoda, Howard I. Scher, et al.. (1988). M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Transitional Cell Carcinoma of the Urothelium. The Journal of Urology. 139(3). 461–469. 492 indexed citations breakdown →

12.

Srinivas, V., Michael J. Morse, H.W. Herr, Pramod C. Sogani, & Willet F. Whitmore. (1987). Penile Cancer: Relation of Extent of Nodal Metastasis to Survival. The Journal of Urology. 137(5). 880–881. 182 indexed citations

13.

Scher, Howard I., William R. Fair, A Yagoda, et al.. (1987). Clinical Downstaging After Neo-Adjuvant M-VAC for Transitional Cell Carcinoma of the Urothelium. The Journal of Urology. 137(6). 2 indexed citations

14.

Klotz, Laurence, Harry W. Herr, Michael J. Morse, & Willet F. Whitmore. (1986). Intermittent endocrine therapy for advanced prostate cancer. Cancer. 58(11). 2546–2550. 171 indexed citations

15.

Morse, Michael J., et al.. (1986). Sequential excision of residual thoracic and retroperitoneal masses after chemotherapy for stage III germ cell tumors. Cancer. 57(5). 978–983. 56 indexed citations

16.

Sternberg, Cora N., Alan Yagoda, Howard I. Scher, et al.. (1985). Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the Urothelium. The Journal of Urology. 133(3). 403–407. 513 indexed citations breakdown →

17.

Huffman, Jeffry L., Demetrius H. Bagley, Edward S. Lyon, et al.. (1985). Endoscopic diagnosis and treatment of upper-tract urothelial tumors. A preliminary report. Cancer. 55(6). 1422–1428. 119 indexed citations

18.

Saltzman, Brian, et al.. (1985). Sacrococcygeal chordoma metastatic to penis. Urology. 25(5). 541–543. 9 indexed citations

19.

Klein, Frederick A., Willet F. Whitmore, Harry W. Herr, Michael J. Morse, & Pramod C. Sogani. (1983). Inferior pubic rami resection with en bloc radical excision for invasive proximal urethral carcinoma. Cancer. 51(7). 1238–1242. 18 indexed citations

20.

Goldenberg, S. Larry, et al.. (1982). A critical evaluation of a specific radioimmunoassay for prostatic acid phosphatase. Cancer. 50(9). 1847–1851. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact